Combination of oral, gene therapies may be best path for geographic atrophy


Share post:

November 25, 2022

1 min watch


Healio Interviews

Eichenbaum reports consulting for Genentech.

We were unable to process your request. Please try again later. If you continue to have this issue please contact

NEW YORK — In this video, David Eichenbaum, MD, director of research at Retina Vitreous Associates of Florida, discussed the outlook for oral therapies in the treatment of geographic atrophy at OSN New York Retina.

Eichenbaum said that oral therapies might provide an easier experience for patients over gene therapies and could ideally work in concert with other therapy programs.

“The ultimate path to treatment may actually include a combination of these therapies inhibiting complement in multiple different ways,” Eichenbaum said.

Source link


Related articles

Inhalable agents in workplace ‘important’ triggers for rheumatoid arthritis

January 31, 2023 2 min read Source/Disclosures Published by: Disclosures: This study was funding by the...

First-Of-Its-Kind $1 Glove Can Detect Fetal Positions To Aid Precarious Births

An ingenious innovation of a smart glove that costs less than $1 has been created with the...

Microneedle Bandage for Hemostatic Control

Scientists at Penn State have developed a microneedle bandage that can rapidly stop bleeding. Uncontrolled bleeding following...